MSW to Become Official Renewable Energy Source

Source: Biomass Power & Thermal, Lisa Gibson (5/19/11)

"Maryland will classify municipal solid waste as a Tier-I renewable."

Biomass Power & Thermal, Lisa Gibson

biomass now a renewable energy source

Maryland Governor Martin O'Malley said he intends to sign into law Senate Bill 690, allowing municipal solid waste to classify as a Tier-I renewable in the state and therefore receive renewable energy credits under its renewable portfolio standard. Under fire for the decision, O'Malley released a lengthy statement May 17 explaining his reasoning and the bill's benefits to Maryland. The state has an aggressive goal of 20% renewable energy by 2022 and will require a diverse fuel mix to accomplish.

"Maryland is not alone in this determination," he continued. "Over half of the states that have a renewable energy goal classify MSW as a renewable fuel. European countries that are many decades ahead of the U.S. in reducing their carbon footprint and reliance on fossil fuels make broad use of modern waste-to-energy facilities and employ comprehensive recycling efforts in order to land fill as little waste as possible."

Marylanders generate tons of waste every day and without waste-to-energy facilities, no value is derived from the waste and the state continues to rely on coal-fired power generation.

O'Malley addressed emissions from waste-to-energy facilities, explaining that they will be more environmentally friendly than the current land-filling and coal-burning strategy. Also, waste-to-energy facilities generally emit lower levels of sulfur and nitrogen oxides and particulate matter per megawatt-hour than coal when used to generate power. But the most troublesome pollutant, he said, is mercury.

"Mercury emissions are the most worrisome aspect of waste-to-energy facilities, but can be limited through vigorous regulation," O'Malley said. "To this end, I have instructed Maryland's Department of the Environment to strictly regulate the amount of mercury emanating from both existing and proposed waste-to-energy facilities in our state.

Novavax Shares Shoot 65% Higher on Phase 3 COVID-19 Vaccine Trial's 89.3% Effectiveness
Source: Streetwise Reports (01/29/2021)

Novavax Inc. shares established a new 52-week high after the firm's COVID-19 vaccine demonstrated an 89.3% efficacy rate in a Phase 3 trial in the U.K. and also showed efficacy against the South African variant in a Phase 2b trial.

Abiomed Shares Gain 8% After Firm Announces Record Q3 Revenue of $232 Million
Source: Streetwise Reports (01/28/2021)

Shares of cardiac medical device maker Abiomed Inc. traded higher after the company reported record revenue for Q3/21 despite the impact from COVID-19.

Sorrento Shares Rise 35% After Firm Posts Positive Data from Phase 1b ICU COVID-19 Trial
Source: Streetwise Reports (01/27/2021)

Shares of Sorrento Therapeutics traded higher after the company released positive preliminary results from it of Phase 1b COVI-MSC™ Study for treatment of hospitalized ICU COVID-19 patients.

Junior Mining Sector 'the Best Value in the Space'
Source: Streetwise Reports (01/27/2021)

The StreetSmart Live! Broadcast on Jan. 26, 2021, focused on metals and why now is a good time for investors to be looking at them and the mining space. John Newell, independent analyst and portfolio manager, and John Feneck, mining sector expert and president of Feneck Consulting, addressed the status of the current metals market. CEOs of the three metals-focused companies comprising the Metallic Group of Companies—Group Ten Metals, Metallic Minerals and Granite Creek Copper—discussed their projects.

Vir Shares Climb 48% on Initial Phase 1 Chronic Hepatitis B Trial Data
Source: Streetwise Reports (01/26/2021)

Vir Biotechnology shares traded higher after the company reported data from its Phase 1 Chronic Hepatitis B Study that showed VIR-3434 significantly and rapidly reduced hepatitis B surface antigen.

Aurinia Pharma Shares Open at 52-Week High as FDA Approves Adult Lupus Nephritis Drug
Source: Streetwise Reports (01/25/2021)

Shares of Aurinia Pharmaceuticals traded 30% higher after the company reported that the U.S. Food and Drug Administration approved its LUPKYNIS™ (voclosporin) for use in treating adults with active lupus nephritis.

AzurRx Doses First Two People in Expanded Phase 2b Trial of Cystic Fibrosis Patients
Source: Streetwise Reports (01/22/2021)

AzurRx BioPharma shares traded 45% higher after the firm advised it had dosed the first two patients in its Phase 2b OPTION 2 Extension Study of MS1819 for treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis.

NGL Energy Shares Rise 21% as It Seeks to Raise $2.05 Billion from Senior Secured Note Offering
Source: Streetwise Reports (01/21/2021)

Shares of NGL Energy Partners LP traded higher after the firm made a series of announcements over the past three days regarding an update on financial operations, a settlement with a customer in bankruptcy, a quarterly Class D unit distribution and a $2.05 billion senior secured debt offering.

Explorer Discovers New Gold Mineralization at Abitibi Gold Belt Property
Source: Streetwise Reports (01/21/2021)

iMetal Resources is setting out to see if the multi-million ounce gold resource next door continues onto its Gowganda West property in Ontario.

Gritstone Oncology Licenses LNP Platform from Genevant Sciences to Develop COVID-19 Vaccine
Source: Streetwise Reports (01/20/2021)

Shares of Gritstone Oncology reached a new 52-week high price after the company advised it entered into a non-exclusive licensing agreement with Genevant Sciences to develop and commercialize self-amplifying RNA vaccines for use against SARS-CoV-2.